EUVIMEDEUVIMED entdecken
Crossref

Management of Acetaminophen Poisoning in the US and Canada

Richard C Dart, Michael E Mullins, Theresa Matoushek, Anne-Michelle Ruha, Michele M Burns, Karen Simone, Michael C Beuhler, Kennon J Heard, Maryann Mazer-Amirshahi, Christine M Stork, Shawn M Varney, Alexandra R Funk und 10 weitere

JAMA Network Open · 08.08.2023 · 6 (8) · e2327739

DOI: 10.1001/jamanetworkopen.2023.27739 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 08.08.2023. Verfasst von Richard C Dart und 21 weiteren Autor:innen. Beteiligte Einrichtung: Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, University of Colorado School of Medicine, Denver. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Poisons. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The US and Canada currently have no formal published nationwide guidelines for specialists in poison information or emergency departments for the management of acetaminophen poisoning, resulting in significant variability in management.

Objective

To develop consensus guidelines for the management of acetaminophen poisoning in the US and Canada. Evidence Review Four clinical toxicology societies (America’s Poison Centers, American Academy of Clinical Toxicology, American College of Medical Toxicology, and Canadian Association of Poison Control Centers) selected participants (n = 21). Led by a nonvoting chairperson using a modified Delphi method, the panel created a decision framework and determined the appropriate clinical management of a patient with acetaminophen poisoning. Unique to this effort was the collection of guidelines from most poison centers in addition to systematic collection and review of the medical literature. Comments from review by external organizations were incorporated before the guideline was finalized. The project began in March 2021 and ended in March 2023.

Findings

The search retrieved 84 guidelines and 278 publications. The panel developed guidelines for emergency department management of single or repeated ingestion of acetaminophen. In addition, the panel addressed extended-release formulation, high-risk ingestion, coingestion of anticholinergics or opioids, age younger than 6 years, pregnancy, weight greater than 100 kg, and intravenous acetaminophen use. Differences from current US practice include defining acute ingestion as an ingestion presentation from 4 to 24 hours after overdose was initiated. A revised form of the Rumack-Matthew nomogram was developed. The term massive ingestion was replaced with the term high-risk ingestion and denoted by a specific nomogram line. Other recommendations include specific criteria for emergency department triage, laboratory evaluation and monitoring parameters, defining the role of gastrointestinal decontamination, detailed management of acetylcysteine treatment, associated adverse effects, and stopping criteria for acetylcysteine treatment, as well as criteria for consultation with a clinical toxicologist. Finally, specific treatment considerations, including acetylcysteine dosing, fomepizole administration, and considerations for extracorporeal elimination and transplant evaluation, were addressed. Conclusions and Relevance This qualitative study provides a consensus statement on consistent evidence-based recommendations for medical, pharmacy, and nursing education and practice to optimize care of patients with acetaminophen poisoning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Related Side Effects and Adverse ReactionsPoisonsHumansChildAcetaminophenAcetylcysteineAmbulatory CareEvidence-Based MedicineCanada

Substanzen

AcetaminophenAcetylcysteinePoisons

Autor:innen und Institutionen

  • Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, University of Colorado School of Medicine, Denver.
  • Department of Emergency Medicine, Washington University School of Medicine, St Louis, Missouri.
  • Missouri Poison Center, St Louis.
  • Banner University Medical Center Phoenix, Phoenix Children's Hospital, University of Arizona College of Medicine, Phoenix.
  • Massachusetts/Rhode Island Poison Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Northern New England Poison Center, Tufts University School of Medicine, Boston, Massachusetts.

Zitieren

APA

Dart, R. C., Mullins, M. E., Matoushek, T., Ruha, A. M., Burns, M. M., Simone, K., Beuhler, M. C., Heard, K. J., Mazer-Amirshahi, M., Stork, C. M., Varney, S. M., Funk, A. R., Cantrell, L. F., Cole, J. B., Banner, W., Stolbach, A. I., Hendrickson, R. G., Lucyk, S. N., Sivilotti, M. L. A., …, & Rumack, B. H. (2023). Management of Acetaminophen Poisoning in the US and Canada. JAMA Network Open, 6(8), e2327739. https://doi.org/10.1001/jamanetworkopen.2023.27739

Vancouver

Dart RC, Mullins ME, Matoushek T, Ruha AM, Burns MM, Simone K, et al. Management of Acetaminophen Poisoning in the US and Canada. JAMA Network Open. 2023;6(8):e2327739. doi:10.1001/jamanetworkopen.2023.27739

BibTeX
@article{Dart2023,
  author = {Dart, Richard C and Mullins, Michael E and Matoushek, Theresa and Ruha, Anne-Michelle and Burns, Michele M and Simone, Karen and Beuhler, Michael C and Heard, Kennon J and Mazer-Amirshahi, Maryann and Stork, Christine M and Varney, Shawn M and Funk, Alexandra R and Cantrell, Lee F and Cole, Jon B and Banner, William and Stolbach, Andrew I and Hendrickson, Robert G and Lucyk, Scott N and Sivilotti, Marco L A and Su, Mark K and Nelson, Lewis S and Rumack, Barry H},
  title = {Management of Acetaminophen Poisoning in the US and Canada},
  journal = {JAMA Network Open},
  year = {2023},
  volume = {6},
  number = {8},
  pages = {e2327739},
  doi = {10.1001/jamanetworkopen.2023.27739}
}
Kostenlos starten →